Study wrapper · #660
[Compensatory and antiamnestic effects of heptapeptide Selank in monkeys].
Editor's note
This preclinical study is notable for its model: monkeys rather than rodents. Researchers reported that intranasal Selank produced long-term changes in monkeys whose behavior had been disrupted by experimentally induced neurosis — reduced fear and aggression, increased exploratory activity, and improved handling and communication — alongside compensation of disturbed memory and homeostatic measures. They contrast Selank with earlier neurohormones (thyroliberin, ACTH4-10), reporting that Selank's anti-stress effects appeared independent of the type of neurotic disturbance and were long-lasting. For Selank, primate data add cross-species weight to its anxiolytic and adaptogenic profile. Weigh it carefully: the abstract gives no sample sizes, controls, or quantified endpoints, the 'neurosis' model and behavioral ratings are observer-dependent, and this is an older report. It is a preclinical, higher-model signal, not clinical proof; human data are needed before clinical conclusions can be drawn.
Plain-language abstract
Most Selank research uses rodents, but this study looked at monkeys. Researchers first induced a disturbed, 'neurotic' behavioral state in the animals, then gave Selank through the nose and observed the effects over time. They reported that Selank led to lasting behavioral improvements: less fear and aggression, more curiosity and exploration, and better handling and social interaction. They also described a long-lasting recovery of disrupted memory and of the animals' internal balance. Compared with two older brain hormones they had studied before, Selank's calming effects seemed to work regardless of the specific type of disturbance and lasted longer. This was a study in monkeys, which are closer to humans than rodents, but the report did not give the number of animals, control comparisons, or precise measurements, and the behavior ratings depend on observers. It is a supportive but early animal finding about Selank's calming effects, not evidence in people.